Dylan Johnson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Dylan Johnson has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
- Joseph Michael Chalovich
East Carolina University
5 shared publications - Jose Renato Pinto
Department of Biomedical Sciences, College of Medicine, Florida State University, Tallahassee, USA
2 shared publications - Adam Schiffenbauer
Environmental Autoimmunity Group, Clinical Research Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, USA
1 shared publication - Alan K. Jarmusch
National Institute of Environmental Health Sciences
1 shared publication Alberto Ferrus
1 shared publication- Alla S. Kostyukova
Voiland School of Chemical Engineering and Bioengineering, Washington State University, Pullman, WA, United States of America
1 shared publication
Latest Publications
- Open Access
- 22 July 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 8948
Lipid-manager autophagy proteins ATG2 and ATG9 regulate extracellular vesicle secretion via amphisome biogenesis and cell lipidome modulation
Autophagy intersects with endocytic trafficking to regulate extracellular vesicle (EV) biogenesis, but how upstream lipid-handling autophagy proteins influence this crosstalk is unclear. Here we show that the autophagy lipid-supply proteins ATG9A and ATG2A/B restrain small EV (sEV) secretion by promoting amphisome formation and controlling cellular lipid composition. Deletion of ATG9A or ATG2A/B in cells, which abolishes autophagosome biogenesis, causes a RAB27A-dependent increase in secretion of CD63-enriched, smaller sEVs, and accumulation of intraluminal vesicles within multivesicular endosomes. Under lysosomal inhibition, wild-type cells release LC3- and autophagy cargo receptor-positive sEVs, whereas ATG9A- and ATG2A/B-deficient cells, despite hypersecretion of sEVs, fail to load LC3 or canonical cargo receptors, indicating a block in amphisome-mediated export. Proteomics reveals selective depletion of autophagy receptors and ferritinophagy factors and enrichment of RNA-binding proteins and endosomal trafficking regulators in sEVs from ATG9A- and ATG2A/B-deficient cells. Whole-cell lipidomics uncovers extensive rewiring of the lipidome, with accumulation of ceramides and neutral lipids, altered phospholipid balance, and transcriptional remodeling of lipid metabolic enzymes, while neutral sphingomyelinase inhibition normalizes sEV output. These findings identify ATG9A and ATG2A/B as lipid-dependent gatekeepers that couple autophagosome and amphisome formation, regulating membrane partition between degradative autophagy and exosome-mediated secretion.
- 22 July 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 8948
Open AccessLipid-manager autophagy proteins ATG2 and ATG9 regulate extracellular vesicle secretion via amphisome biogenesis and cell lipidome modulation
Autophagy intersects with endocytic trafficking to regulate extracellular vesicle (EV) biogenesis, but how upstream lipid-handling autophagy proteins influence this crosstalk is unclear. Here we show that the autophagy lipid-supply proteins ATG9A and ATG2A/B restrain small EV (sEV) secretion by promoting amphisome formation and controlling cellular lipid composition. Deletion of ATG9A or ATG2A/B in cells, which abolishes autophagosome biogenesis, causes a RAB27A-dependent increase in secretion of CD63-enriched, smaller sEVs, and accumulation of intraluminal vesicles within multivesicular endosomes. Under lysosomal inhibition, wild-type cells release LC3- and autophagy cargo receptor-positive sEVs, whereas ATG9A- and ATG2A/B-deficient cells, despite hypersecretion of sEVs, fail to load LC3 or canonical cargo receptors, indicating a block in amphisome-mediated export. Proteomics reveals selective depletion of autophagy receptors and ferritinophagy factors and enrichment of RNA-binding proteins and endosomal trafficking regulators in sEVs from ATG9A- and ATG2A/B-deficient cells. Whole-cell lipidomics uncovers extensive rewiring of the lipidome, with accumulation of ceramides and neutral lipids, altered phospholipid balance, and transcriptional remodeling of lipid metabolic enzymes, while neutral sphingomyelinase inhibition normalizes sEV output. These findings identify ATG9A and ATG2A/B as lipid-dependent gatekeepers that couple autophagosome and amphisome formation, regulating membrane partition between degradative autophagy and exosome-mediated secretion.
- Open Access
- 29 April 2026
- Published by Springer Nature in Metabolomics
- Vol. 22 (3) , 60
Untargeted metabolomics reveals serum metabolites related to energy metabolism and inflammation associated with juvenile dermatomyositis
Introduction: Juvenile dermatomyositis (JDM) is a rare autoimmune inflammatory myopathy characterized by muscle weakness and distinctive skin rashes. Despite advancements in the clinical understanding of JDM, metabolic disturbances underlying the disease remain poorly understood. Objectives: This study aimed to investigate serum metabolite differences in JDM compared to age- and sex-matched unaffected siblings (US) and unrelated healthy controls (HC), and to identify metabolite abundance differences associated with disease severity. Methods: Serum samples from JDM (n = 16) and adult dermatomyositis (DM; n = 15) patients and corresponding US and HC underwent untargeted metabolomics profiling. Multivariate, univariate, and correlation analyses were employed to identify metabolites differentiating groups and correlating with Physician Global Damage (PGD) scores. Results: JDM patients exhibited modest but discernible alterations in serum metabolites compared to controls, many of which also correlated with PGD. Several bioactive lipids and pyroglutamic acid were upregulated in JDM and positively correlated with PGD. Changes in xanthine, methionine and N-acetylneuraminic acid also indicated increased oxidative stress and inflammation. Markers of increased energy demand and muscle damage, including acylcarnitines, creatine, 4-guanidinobutyric acid, glutamine, and phenylacetylglutamine, were differential and correlated with PGD in some cases. A metabolite abundance gradient from JDM to US to HC groups suggests that siblings help account for genetic and environmental influences on the metabolome. DM patients did not show significant serum changes compared to US. Conclusion: Untargeted metabolomics revealed distinct serum metabolite alterations in JDM, providing insights into disease-related metabolic perturbations. These findings enhance understanding of JDM pathophysiology and inform future large-scale, targeted studies.
- 29 April 2026
- Published by Springer Nature in Metabolomics
- Vol. 22 (3) , 60
Open AccessUntargeted metabolomics reveals serum metabolites related to energy metabolism and inflammation associated with juvenile dermatomyositis
Introduction: Juvenile dermatomyositis (JDM) is a rare autoimmune inflammatory myopathy characterized by muscle weakness and distinctive skin rashes. Despite advancements in the clinical understanding of JDM, metabolic disturbances underlying the disease remain poorly understood. Objectives: This study aimed to investigate serum metabolite differences in JDM compared to age- and sex-matched unaffected siblings (US) and unrelated healthy controls (HC), and to identify metabolite abundance differences associated with disease severity. Methods: Serum samples from JDM (n = 16) and adult dermatomyositis (DM; n = 15) patients and corresponding US and HC underwent untargeted metabolomics profiling. Multivariate, univariate, and correlation analyses were employed to identify metabolites differentiating groups and correlating with Physician Global Damage (PGD) scores. Results: JDM patients exhibited modest but discernible alterations in serum metabolites compared to controls, many of which also correlated with PGD. Several bioactive lipids and pyroglutamic acid were upregulated in JDM and positively correlated with PGD. Changes in xanthine, methionine and N-acetylneuraminic acid also indicated increased oxidative stress and inflammation. Markers of increased energy demand and muscle damage, including acylcarnitines, creatine, 4-guanidinobutyric acid, glutamine, and phenylacetylglutamine, were differential and correlated with PGD in some cases. A metabolite abundance gradient from JDM to US to HC groups suggests that siblings help account for genetic and environmental influences on the metabolome. DM patients did not show significant serum changes compared to US. Conclusion: Untargeted metabolomics revealed distinct serum metabolite alterations in JDM, providing insights into disease-related metabolic perturbations. These findings enhance understanding of JDM pathophysiology and inform future large-scale, targeted studies.
- 9 September 2020
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 59 (37) , 3487-3497
Eliminating the First Inactive State and Stabilizing the Active State of the Cardiac Regulatory System Alters Behavior in Solution and in Ordered Systems
Calcium binding to troponin C is insufficient for full activation of myosin ATPase activity by actin-tropomyosin-troponin. Previous attempts to investigate full activation utilized ATP-free myosin or chemically modified myosin to stabilize the active state of regulated actin. We utilized the Δ14-TnT and the A8V TnC mutants to stabilize the activate state at saturating Ca2+ and to eliminate one of the inactive states at low Ca2+. The observed effects differed in solution studies and in the more ordered in vitro motility assay and in skinned cardiac muscle preparations. At saturating Ca2+, full activation with Δ14-TnT•A8V-TnC decreased the apparent KM for actin-activated ATPase activity compared to bare actin filaments. Rates of in vitro motility increased at both high and low Ca2+ with Δ14-TnT; the maximum shortening speed at high Ca2+ increased 1.8-fold. Cardiac muscle preparations exhibited increased Ca2+ sensitivity and large increases in resting force with either Δ14-TnT or Δ14-TnT•A8V-TnC. We also observed a significant increase in maximal rate of tension redevelopment. The results of full activation with Ca2+ and Δ14-TnT•A8V-TnC confirmed and extended several earlier observations using other means of reaching full activation. Furthermore, at low Ca2+, elimination of the 1st inactive state led to partial activation. This work also confirms, in 3 distinct experimental systems, that troponin is able to stabilize the active state of actin-tropomyosin-troponin without the need for high affinity myosin binding. The results are relevant to the reason for 2 inactive states and for the role of force producing myosin in regulation.
- 9 September 2020
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 59 (37) , 3487-3497
Eliminating the First Inactive State and Stabilizing the Active State of the Cardiac Regulatory System Alters Behavior in Solution and in Ordered Systems
Calcium binding to troponin C is insufficient for full activation of myosin ATPase activity by actin-tropomyosin-troponin. Previous attempts to investigate full activation utilized ATP-free myosin or chemically modified myosin to stabilize the active state of regulated actin. We utilized the Δ14-TnT and the A8V TnC mutants to stabilize the activate state at saturating Ca2+ and to eliminate one of the inactive states at low Ca2+. The observed effects differed in solution studies and in the more ordered in vitro motility assay and in skinned cardiac muscle preparations. At saturating Ca2+, full activation with Δ14-TnT•A8V-TnC decreased the apparent KM for actin-activated ATPase activity compared to bare actin filaments. Rates of in vitro motility increased at both high and low Ca2+ with Δ14-TnT; the maximum shortening speed at high Ca2+ increased 1.8-fold. Cardiac muscle preparations exhibited increased Ca2+ sensitivity and large increases in resting force with either Δ14-TnT or Δ14-TnT•A8V-TnC. We also observed a significant increase in maximal rate of tension redevelopment. The results of full activation with Ca2+ and Δ14-TnT•A8V-TnC confirmed and extended several earlier observations using other means of reaching full activation. Furthermore, at low Ca2+, elimination of the 1st inactive state led to partial activation. This work also confirms, in 3 distinct experimental systems, that troponin is able to stabilize the active state of actin-tropomyosin-troponin without the need for high affinity myosin binding. The results are relevant to the reason for 2 inactive states and for the role of force producing myosin in regulation.
- Open Access
- 15 January 2019
- Published by American Society for Cell Biology (ASCB) in Molecular Biology of the Cell
- Vol. 30 (2) , 268-281
Effects of cardiomyopathy-linked mutations K15N and R21H in tropomyosin on thin-filament regulation and pointed-end dynamics
Missense mutations K15N and R21H in striated muscle tropomyosin are linked to dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM), respectively. Tropomyosin, together with the troponin complex, regulates muscle contraction and, along with tropomodulin and leiomodin, controls the uniform thin-filament lengths crucial for normal sarcomere structure and function. We used Förster resonance energy transfer to study effects of the tropomyosin mutations on the structure and kinetics of the cardiac troponin core domain associated with the Ca2+-dependent regulation of cardiac thin filaments. We found that the K15N mutation desensitizes thin filaments to Ca2+and slows the kinetics of structural changes in troponin induced by Ca2+dissociation from troponin, while the R21H mutation has almost no effect on these parameters. Expression of the K15N mutant in cardiomyocytes decreases leiomodin’s thin-filament pointed-end assembly but does not affect tropomodulin’s assembly at the pointed end. Our in vitro assays show that the R21H mutation causes a twofold decrease in tropomyosin’s affinity for F-actin and affects leiomodin’s function. We suggest that the K15N mutation causes DCM by altering Ca2+-dependent thin-filament regulation and that one of the possible HCM-causing mechanisms by the R21H mutation is through alteration of leiomodin’s function.
- 15 January 2019
- Published by American Society for Cell Biology (ASCB) in Molecular Biology of the Cell
- Vol. 30 (2) , 268-281
Open AccessEffects of cardiomyopathy-linked mutations K15N and R21H in tropomyosin on thin-filament regulation and pointed-end dynamics
Missense mutations K15N and R21H in striated muscle tropomyosin are linked to dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM), respectively. Tropomyosin, together with the troponin complex, regulates muscle contraction and, along with tropomodulin and leiomodin, controls the uniform thin-filament lengths crucial for normal sarcomere structure and function. We used Förster resonance energy transfer to study effects of the tropomyosin mutations on the structure and kinetics of the cardiac troponin core domain associated with the Ca2+-dependent regulation of cardiac thin filaments. We found that the K15N mutation desensitizes thin filaments to Ca2+and slows the kinetics of structural changes in troponin induced by Ca2+dissociation from troponin, while the R21H mutation has almost no effect on these parameters. Expression of the K15N mutant in cardiomyocytes decreases leiomodin’s thin-filament pointed-end assembly but does not affect tropomodulin’s assembly at the pointed end. Our in vitro assays show that the R21H mutation causes a twofold decrease in tropomyosin’s affinity for F-actin and affects leiomodin’s function. We suggest that the K15N mutation causes DCM by altering Ca2+-dependent thin-filament regulation and that one of the possible HCM-causing mechanisms by the R21H mutation is through alteration of leiomodin’s function.
- 1 October 2018
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1860 (10) , 1985-1993
Docosahexaenoic acid regulates the formation of lipid rafts: A unified view from experiment and simulation
- 1 October 2018
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1860 (10) , 1985-1993
Docosahexaenoic acid regulates the formation of lipid rafts: A unified view from experiment and simulation
- 21 August 2018
- Published by Elsevier in Biophysical Journal
- Vol. 115 (4) , 702-712
Stepwise C-Terminal Truncation of Cardiac Troponin T Alters Function at Low and Saturating Ca2+
- 21 August 2018
- Published by Elsevier in Biophysical Journal
- Vol. 115 (4) , 702-712
Stepwise C-Terminal Truncation of Cardiac Troponin T Alters Function at Low and Saturating Ca2+
- 22 May 2017
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 56 (23) , 2928-2937
Troponin C Mutations Partially Stabilize the Active State of Regulated Actin and Fully Stabilize the Active State When Paired with Δ14 TnT
Striated muscle contraction is regulated by the actin-associated proteins tropomyosin and troponin. The extent of activation of myosin ATPase activity is lowest in the absence of both Ca2+ and activating cross-bridges (i.e., S1-ADP or rigor S1). Binding of activating species of myosin to actin at a saturating Ca2+ concentration stabilizes the most active state (M state) of the actin–tropomyosin–troponin complex (regulated actin). Ca2+ binding alone produces partial stabilization of the active state. The extent of stabilization at a saturating Ca2+ concentration depends on the isoform of the troponin subunits, the phosphorylation state of troponin, and, in the case of cardiac muscle, the presence of hypertrophic cardiomyopathy-producing mutants of troponin T and troponin I. Cardiac dysfunction is also associated with mutations of troponin C (TnC). Troponin C mutants A8V, C84Y, and D145E increase the Ca2+ sensitivity of ATPase activity. We show that these mutants change the distribution of regulated actin states. The A8V and C84Y TnC mutants decreased the inactive B state distribution slightly at low Ca2+ concentrations, but the D145E mutants had no effect on that state. All TnC mutants increased the level of the active M state compared to that of the wild type, at a saturating Ca2+ concentration. Troponin complexes that contained two mutations that stabilize the active M state, A8V TnC and Δ14 TnT, appeared to be completely in the active state in the presence of only Ca2+. Because Ca2+ gives full activation, in this situation, troponin must be capable of positioning tropomyosin in the active M state without the need for rigor myosin binding.
- 22 May 2017
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 56 (23) , 2928-2937
Troponin C Mutations Partially Stabilize the Active State of Regulated Actin and Fully Stabilize the Active State When Paired with Δ14 TnT
Striated muscle contraction is regulated by the actin-associated proteins tropomyosin and troponin. The extent of activation of myosin ATPase activity is lowest in the absence of both Ca2+ and activating cross-bridges (i.e., S1-ADP or rigor S1). Binding of activating species of myosin to actin at a saturating Ca2+ concentration stabilizes the most active state (M state) of the actin–tropomyosin–troponin complex (regulated actin). Ca2+ binding alone produces partial stabilization of the active state. The extent of stabilization at a saturating Ca2+ concentration depends on the isoform of the troponin subunits, the phosphorylation state of troponin, and, in the case of cardiac muscle, the presence of hypertrophic cardiomyopathy-producing mutants of troponin T and troponin I. Cardiac dysfunction is also associated with mutations of troponin C (TnC). Troponin C mutants A8V, C84Y, and D145E increase the Ca2+ sensitivity of ATPase activity. We show that these mutants change the distribution of regulated actin states. The A8V and C84Y TnC mutants decreased the inactive B state distribution slightly at low Ca2+ concentrations, but the D145E mutants had no effect on that state. All TnC mutants increased the level of the active M state compared to that of the wild type, at a saturating Ca2+ concentration. Troponin complexes that contained two mutations that stabilize the active M state, A8V TnC and Δ14 TnT, appeared to be completely in the active state in the presence of only Ca2+. Because Ca2+ gives full activation, in this situation, troponin must be capable of positioning tropomyosin in the active M state without the need for rigor myosin binding.
- Open Access
- 31 August 2016
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 7, 377
Commentary: Effect of Skeletal Muscle Native Tropomyosin on the Interaction of Amoeba Actin with Heavy Meromyosin
A commentary on Effect of Skeletal Muscle Native Tropomyosin on the Interaction of Amoeba Actin with Heavy Meromyosin by Eisenberg, E., and Weihing, R. R. (1970). Nature 228, 1092–1093. doi: 10.1038/2281092a0 Troponin-tropomyosin inhibits skeletal and cardiac muscle contraction at low Ca2+. Binding of rigor-type myosin S1 to actin-tropomyosin-troponin, particularly at saturating Ca2+, produces activation of myosin ATPase activity in excess of that seen in the absence of the regulatory proteins. The binding energy of S1 can overcome the inhibitory activity of troponin (Bremel et al., 1972) and may allow tropomyosin to move deep into the groove of actin. That particular arrangement of actin, tropomyosin, and troponin is a much better activator of ATP hydrolysis than actin alone. That active configuration of actin was called state 2 in the Hill model (Hill et al., 1980) and later named the M state because of its requirement for tight myosin binding. Eisenberg and Weihing found evidence that troponin itself can stabilize the active state of actin in the absence of high affinity S1 binding (Eisenberg and Weihing, 1970). They showed that troponin-tropomyosin enhanced the ability of amoeba actin to activate myosin S1 ATPase activity at high Ca2+. That observation is often overlooked but may be an important clue to managing some muscle disorders. Actin filaments containing the hypertrophic cardiomyopathy associated Δ14 mutation of TnT also enhanced S1 ATPase rates 2-3-fold higher than actin filaments without bound regulatory proteins (Gafurov et al., 2004). Because small changes in the structure of actin or troponin allow this increased activation to occur, the troponin complex must have a latent ability to enhance actin activation of myosin ATPase activity. The 14 C-terminal residues of TnT attenuate the ability of troponin to enhance actin activation. Troponin containing Δ14 TnT might act by stabilizing tropomyosin in the M state position of the actin groove under saturating Ca2+ conditions. The inactive state of actin-tropomyosin-troponin (state 1 or the B state) occurs at low free Ca2+ when the inhibitory region of TnI is bound to actin. Because of associations among the regulatory proteins, tropomyosin is stabilized outside of the actin groove and there is little stimulation of myosin ATPase activity. Removal of the 14 C-terminal residues of TnT prevents formation of the B state. Compared with wild type actin filaments in EGTA, those containing Δ14 TnT exhibit less cooperativity in equilibrium binding of myosin S1 (Gafurov et al., 2004), and they do not exhibit the acrylodan tropomyosin fluorescence increase under conditions favoring the inactive state (Borrego-Diaz and Chalovich, 2010; Franklin et al., 2012). Ca2+ binding to TnC opens a hydrophobic patch to which the switch region of TnI can bind (Herzberg et al., 1986). Under this condition, TnI is detached from actin and tropomyosin is situated in the actin groove. Several lines of evidence indicate that the major state formed with Ca2+ is a second inactive state with tropomyosin partially in the actin groove (Trybus and Taylor, 1980; McKillop and Geeves, 1991; Lehman et al., 2001; Kimura et al., 2002; Pirani et al., 2005; Poole et al., 2006). Full movement into the groove to form the active M state requires rigor S1 binding or a structural change in troponin. In the Hill model of regulation, Ca2+ binding to troponin was thought to create an inactive state 1 with bound Ca2+. State 1 with bound Ca2+ may be equivalent to the state intermediate between the B and M states that is called the C state (because of its link to Ca2+). The level of activation of ATPase activity at saturating Ca2+ is determined by the amount of M state formed in its equilibrium with the C state. The major state formed with Δ14 TnT containing actin filaments at low Ca2+ is likely to be the C state as the B state cannot form. The C state is also stabilized by a hypertrophic cardiomyopathy causing mutation, R146G TnI. The R146G mutation in TnI gives relative stabilization to the C state at low Ca2+ and the C state is highly stabilized at saturating Ca2+(Mathur et al., 2009). An analysis of ATPase rates of R146G TnI containing actin filaments supported the idea that the C state is ineffective in stimulating myosin ATPase activity. Studying natural mutations and modifications of troponin has given muscle researchers insights into the regulation of contraction. Long term deviations from the normal distribution of B, C, and M states of regulated actin seem to lead to progressive cardiac dysfunction. The last 14 residues of human cardiac TnT are critical for controlling the equilibria among the B, C, and M states of regulated actin; they stabilize the B state at low Ca2+ and destabilize the M state at saturating Ca2+. Table 1 compares the C-terminal sequences of several forms of troponin T. Note the conservation of the four terminal residues and the pattern of basic residues (bold). The regularly spaced basic residues suggest the possibility of acidic target sites for controlling both the B and M states. Table 1. C-terminal troponin T sequence comparison. The C-terminal region of TnT might function by directly affecting movement of tropomyosin on the actin surface. The C-terminal region could destabilize the active M state at saturating Ca2+ by interfering with tropomyosin movement into the actin groove. At low Ca2+, the C-terminal region of TnT could participate in holding tropomyosin away from the actin groove. The C-terminal 14 residues of TnT could also potentially alter the pathway of transmission of information from Ca2+ binding to TnC through the events leading to tropomyosin repositioning. Deciphering the mechanisms of action of the C-terminal region of TnT may lead to new therapies for cardiac disorders. All authors listed, have made substantial, direct and intellectual contribution to the work, and approved it for publication. Funded by NIH grant AR44504 and the Brody Brothers Grant to JC. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Borrego-Diaz, E., and Chalovich, J. M. (2010). Kinetics of regulated actin transitions measured by probes on tropomyosin. Biophys. J. 98, 2601–2609. doi: 10.1016/j.bpj.2010.02.030 PubMed Abstract | CrossRef Full Text | Google Scholar Bremel, R. D., Murray, J. M., and Weber, A. (1972). Manifestations of cooperative behavior in the regulated actin filament during actin-activated ATP hydrolysis in the presence of calcium. Cold Spring Harb. Symp. Quant. Biol. (Basel) 37, 267–275. Google Scholar Eisenberg, E., and Weihing, R. R. (1970). Effect of skeletal muscle native tropomyosin on the interaction of amoeba actin with heavy meromyosin. Nature 228, 1092–1093. doi: 10.1038/2281092a0 PubMed Abstract | CrossRef Full Text | Google Scholar Franklin, A. J., Baxley, T., Kobayashi, T., and Chalovich, J. M. (2012). The C-terminus of troponin T is essential for maintaining the inactive state of regulated actin. Biophys. J. 102, 2536–2544. doi: 10.1016/j.bpj.2012.04.037 PubMed Abstract | CrossRef Full Text | Google Scholar Gafurov, B., Fredricksen, S., Cai, A., Brenner, B., Chase, P. B., and Chalovich, J. M. (2004). The Δ14 mutation of human cardiac troponin T enhances ATPase activity and alters the cooperative binding of S1-ADP to regulated actin. Biochemistry 43, 15276–15285. doi: 10.1021/bi048646h PubMed Abstract | CrossRef Full Text | Google Scholar Herzberg, O., Moult, J., and James, M. N. (1986). A model for the Ca2+-induced conformational transition of troponin C. A trigger for muscle contraction. J. Biol.Chem. 261, 2638–2644. PubMed Abstract | Google Scholar Hill, T. L., Eisenberg, E., and Greene, L. E. (1980). Theoretical model for the cooperative equilibrium binding of myosin subfragment 1 to the actin-troponin-tropomyosin complex. Proc. Natl. Acad. Sci. U.S.A. 77, 3186–3190. PubMed Abstract | Google Scholar Kimura, C., Maeda, K., Maeda, Y., and Miki, M. (2002). Ca2+S1-induced movement of troponin T on reconstituted skeletal muscle thin filaments observed by fluorescence energy transfer spectroscopy. J. Biochem. 132, 93–102. doi: 10.1093/oxfordjournals.jbchem.a003204 PubMed Abstract | CrossRef Full Text | Google Scholar Lehman, W., Rosol, M., Tobacman, L. S., and Craig, R. (2001). Troponin organization on relaxed and activated thin filaments revealed by electron microscopy and three-dimensional reconstruction. J. Mol. Biol. 307, 739–744. doi: 10.1006/jmbi.2001.4514 PubMed Abstract | CrossRef Full Text | Google Scholar Mathur, M. C., Kobayashi, T., and Chalovich, J. M. (2009). Some cardiomyopathy causing troponin I mutations stabilize a functional intermediate actin state. Biophys. J. 96, 2237–2244. doi: 10.1016/j.bpj.2008.12.3909 PubMed Abstract | CrossRef Full Text | Google Scholar McKillop, D. F. A., and Geeves, M. A. (1991). Regulation of the actomyosin subfragment 1 interaction by troponin/tropomyosin. Evidence for control of a specific isomerization between two actoùmyosin subfragment 1 states. Biochem. J. 279, 711–718. PubMed Abstract Pirani, A., Xu, C., Hatch, V., Craig, R., Tobacman, L. S., and Lehman, W. (2005). Single particle analysis of relaxed and activated muscle thin filaments. J. Mol. Biol. 346, 761–772. doi: 10.1016/j.jmb.2004.12.013 PubMed Abstract | CrossRef Full Text | Google Scholar Poole, K. J. V., Lorenz, M., Evans, G., Rosenbaum, G., Pirani, A., Craig, R., et al. (2006). A comparison of muscle thin filament models obtained from electron microscopy reconstructions and low-angle X-ray fibre diagrams from non-overlap muscle. J. Struct. Biol. 155, 273–284. doi: 10.1016/j.jsb.2006.02.020 PubMed Abstract | CrossRef Full Text | Google Scholar Trybus, K. M., and Taylor, E. W. (1980). Kinetic studies of the cooperative binding of subfragment 1 to regulated actin. Proc. Natl. Acad. Sci. U.S.A. 77, 7209–7213. PubMed Abstract | Google Scholar Keywords: troponin, tropomyosin, cardiomyopathy, troponin T, mutations Citation: Chalovich JM and Johnson D (2016) Commentary: Effect of Skeletal Muscle Native Tropomyosin on the Interaction of Amoeba Actin with Heavy Meromyosin. Front. Physiol. 7:377. doi: 10.3389/fphys.2016.00377 Received: 28 June 2016; Accepted: 15 August 2016; Published: 31 August 2016. Edited by: Reviewed by: Copyright © 2016 Chalovich and Johnson. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. *Correspondence: Joseph M. Chalovich, chalovichj@ecu.edu
- 31 August 2016
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 7, 377
Open AccessCommentary: Effect of Skeletal Muscle Native Tropomyosin on the Interaction of Amoeba Actin with Heavy Meromyosin
A commentary on Effect of Skeletal Muscle Native Tropomyosin on the Interaction of Amoeba Actin with Heavy Meromyosin by Eisenberg, E., and Weihing, R. R. (1970). Nature 228, 1092–1093. doi: 10.1038/2281092a0 Troponin-tropomyosin inhibits skeletal and cardiac muscle contraction at low Ca2+. Binding of rigor-type myosin S1 to actin-tropomyosin-troponin, particularly at saturating Ca2+, produces activation of myosin ATPase activity in excess of that seen in the absence of the regulatory proteins. The binding energy of S1 can overcome the inhibitory activity of troponin (Bremel et al., 1972) and may allow tropomyosin to move deep into the groove of actin. That particular arrangement of actin, tropomyosin, and troponin is a much better activator of ATP hydrolysis than actin alone. That active configuration of actin was called state 2 in the Hill model (Hill et al., 1980) and later named the M state because of its requirement for tight myosin binding. Eisenberg and Weihing found evidence that troponin itself can stabilize the active state of actin in the absence of high affinity S1 binding (Eisenberg and Weihing, 1970). They showed that troponin-tropomyosin enhanced the ability of amoeba actin to activate myosin S1 ATPase activity at high Ca2+. That observation is often overlooked but may be an important clue to managing some muscle disorders. Actin filaments containing the hypertrophic cardiomyopathy associated Δ14 mutation of TnT also enhanced S1 ATPase rates 2-3-fold higher than actin filaments without bound regulatory proteins (Gafurov et al., 2004). Because small changes in the structure of actin or troponin allow this increased activation to occur, the troponin complex must have a latent ability to enhance actin activation of myosin ATPase activity. The 14 C-terminal residues of TnT attenuate the ability of troponin to enhance actin activation. Troponin containing Δ14 TnT might act by stabilizing tropomyosin in the M state position of the actin groove under saturating Ca2+ conditions. The inactive state of actin-tropomyosin-troponin (state 1 or the B state) occurs at low free Ca2+ when the inhibitory region of TnI is bound to actin. Because of associations among the regulatory proteins, tropomyosin is stabilized outside of the actin groove and there is little stimulation of myosin ATPase activity. Removal of the 14 C-terminal residues of TnT prevents formation of the B state. Compared with wild type actin filaments in EGTA, those containing Δ14 TnT exhibit less cooperativity in equilibrium binding of myosin S1 (Gafurov et al., 2004), and they do not exhibit the acrylodan tropomyosin fluorescence increase under conditions favoring the inactive state (Borrego-Diaz and Chalovich, 2010; Franklin et al., 2012). Ca2+ binding to TnC opens a hydrophobic patch to which the switch region of TnI can bind (Herzberg et al., 1986). Under this condition, TnI is detached from actin and tropomyosin is situated in the actin groove. Several lines of evidence indicate that the major state formed with Ca2+ is a second inactive state with tropomyosin partially in the actin groove (Trybus and Taylor, 1980; McKillop and Geeves, 1991; Lehman et al., 2001; Kimura et al., 2002; Pirani et al., 2005; Poole et al., 2006). Full movement into the groove to form the active M state requires rigor S1 binding or a structural change in troponin. In the Hill model of regulation, Ca2+ binding to troponin was thought to create an inactive state 1 with bound Ca2+. State 1 with bound Ca2+ may be equivalent to the state intermediate between the B and M states that is called the C state (because of its link to Ca2+). The level of activation of ATPase activity at saturating Ca2+ is determined by the amount of M state formed in its equilibrium with the C state. The major state formed with Δ14 TnT containing actin filaments at low Ca2+ is likely to be the C state as the B state cannot form. The C state is also stabilized by a hypertrophic cardiomyopathy causing mutation, R146G TnI. The R146G mutation in TnI gives relative stabilization to the C state at low Ca2+ and the C state is highly stabilized at saturating Ca2+(Mathur et al., 2009). An analysis of ATPase rates of R146G TnI containing actin filaments supported the idea that the C state is ineffective in stimulating myosin ATPase activity. Studying natural mutations and modifications of troponin has given muscle researchers insights into the regulation of contraction. Long term deviations from the normal distribution of B, C, and M states of regulated actin seem to lead to progressive cardiac dysfunction. The last 14 residues of human cardiac TnT are critical for controlling the equilibria among the B, C, and M states of regulated actin; they stabilize the B state at low Ca2+ and destabilize the M state at saturating Ca2+. Table 1 compares the C-terminal sequences of several forms of troponin T. Note the conservation of the four terminal residues and the pattern of basic residues (bold). The regularly spaced basic residues suggest the possibility of acidic target sites for controlling both the B and M states. Table 1. C-terminal troponin T sequence comparison. The C-terminal region of TnT might function by directly affecting movement of tropomyosin on the actin surface. The C-terminal region could destabilize the active M state at saturating Ca2+ by interfering with tropomyosin movement into the actin groove. At low Ca2+, the C-terminal region of TnT could participate in holding tropomyosin away from the actin groove. The C-terminal 14 residues of TnT could also potentially alter the pathway of transmission of information from Ca2+ binding to TnC through the events leading to tropomyosin repositioning. Deciphering the mechanisms of action of the C-terminal region of TnT may lead to new therapies for cardiac disorders. All authors listed, have made substantial, direct and intellectual contribution to the work, and approved it for publication. Funded by NIH grant AR44504 and the Brody Brothers Grant to JC. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Borrego-Diaz, E., and Chalovich, J. M. (2010). Kinetics of regulated actin transitions measured by probes on tropomyosin. Biophys. J. 98, 2601–2609. doi: 10.1016/j.bpj.2010.02.030 PubMed Abstract | CrossRef Full Text | Google Scholar Bremel, R. D., Murray, J. M., and Weber, A. (1972). Manifestations of cooperative behavior in the regulated actin filament during actin-activated ATP hydrolysis in the presence of calcium. Cold Spring Harb. Symp. Quant. Biol. (Basel) 37, 267–275. Google Scholar Eisenberg, E., and Weihing, R. R. (1970). Effect of skeletal muscle native tropomyosin on the interaction of amoeba actin with heavy meromyosin. Nature 228, 1092–1093. doi: 10.1038/2281092a0 PubMed Abstract | CrossRef Full Text | Google Scholar Franklin, A. J., Baxley, T., Kobayashi, T., and Chalovich, J. M. (2012). The C-terminus of troponin T is essential for maintaining the inactive state of regulated actin. Biophys. J. 102, 2536–2544. doi: 10.1016/j.bpj.2012.04.037 PubMed Abstract | CrossRef Full Text | Google Scholar Gafurov, B., Fredricksen, S., Cai, A., Brenner, B., Chase, P. B., and Chalovich, J. M. (2004). The Δ14 mutation of human cardiac troponin T enhances ATPase activity and alters the cooperative binding of S1-ADP to regulated actin. Biochemistry 43, 15276–15285. doi: 10.1021/bi048646h PubMed Abstract | CrossRef Full Text | Google Scholar Herzberg, O., Moult, J., and James, M. N. (1986). A model for the Ca2+-induced conformational transition of troponin C. A trigger for muscle contraction. J. Biol.Chem. 261, 2638–2644. PubMed Abstract | Google Scholar Hill, T. L., Eisenberg, E., and Greene, L. E. (1980). Theoretical model for the cooperative equilibrium binding of myosin subfragment 1 to the actin-troponin-tropomyosin complex. Proc. Natl. Acad. Sci. U.S.A. 77, 3186–3190. PubMed Abstract | Google Scholar Kimura, C., Maeda, K., Maeda, Y., and Miki, M. (2002). Ca2+S1-induced movement of troponin T on reconstituted skeletal muscle thin filaments observed by fluorescence energy transfer spectroscopy. J. Biochem. 132, 93–102. doi: 10.1093/oxfordjournals.jbchem.a003204 PubMed Abstract | CrossRef Full Text | Google Scholar Lehman, W., Rosol, M., Tobacman, L. S., and Craig, R. (2001). Troponin organization on relaxed and activated thin filaments revealed by electron microscopy and three-dimensional reconstruction. J. Mol. Biol. 307, 739–744. doi: 10.1006/jmbi.2001.4514 PubMed Abstract | CrossRef Full Text | Google Scholar Mathur, M. C., Kobayashi, T., and Chalovich, J. M. (2009). Some cardiomyopathy causing troponin I mutations stabilize a functional intermediate actin state. Biophys. J. 96, 2237–2244. doi: 10.1016/j.bpj.2008.12.3909 PubMed Abstract | CrossRef Full Text | Google Scholar McKillop, D. F. A., and Geeves, M. A. (1991). Regulation of the actomyosin subfragment 1 interaction by troponin/tropomyosin. Evidence for control of a specific isomerization between two actoùmyosin subfragment 1 states. Biochem. J. 279, 711–718. PubMed Abstract Pirani, A., Xu, C., Hatch, V., Craig, R., Tobacman, L. S., and Lehman, W. (2005). Single particle analysis of relaxed and activated muscle thin filaments. J. Mol. Biol. 346, 761–772. doi: 10.1016/j.jmb.2004.12.013 PubMed Abstract | CrossRef Full Text | Google Scholar Poole, K. J. V., Lorenz, M., Evans, G., Rosenbaum, G., Pirani, A., Craig, R., et al. (2006). A comparison of muscle thin filament models obtained from electron microscopy reconstructions and low-angle X-ray fibre diagrams from non-overlap muscle. J. Struct. Biol. 155, 273–284. doi: 10.1016/j.jsb.2006.02.020 PubMed Abstract | CrossRef Full Text | Google Scholar Trybus, K. M., and Taylor, E. W. (1980). Kinetic studies of the cooperative binding of subfragment 1 to regulated actin. Proc. Natl. Acad. Sci. U.S.A. 77, 7209–7213. PubMed Abstract | Google Scholar Keywords: troponin, tropomyosin, cardiomyopathy, troponin T, mutations Citation: Chalovich JM and Johnson D (2016) Commentary: Effect of Skeletal Muscle Native Tropomyosin on the Interaction of Amoeba Actin with Heavy Meromyosin. Front. Physiol. 7:377. doi: 10.3389/fphys.2016.00377 Received: 28 June 2016; Accepted: 15 August 2016; Published: 31 August 2016. Edited by: Reviewed by: Copyright © 2016 Chalovich and Johnson. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. *Correspondence: Joseph M. Chalovich, chalovichj@ecu.edu
- 3 August 2016
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 55 (32) , 4533-4540
The Cardiomyopathy Mutation, R146G Troponin I, Stabilizes the Intermediate “C” State of Regulated Actin under High- and Low-Free Ca2+ Conditions
The R146G mutation of troponin I (TnI) is associated with hypertrophic cardiomyopathy in humans. Earlier data pointed to stabilization of the intermediate, C state, of actin–tropomyosin–troponin by this mutant. Because cardiac disorders appear to be linked to changes in regulated actin distributions, we determined the extent to which the R146G TnI mutant alters the distribution of states at low and high Ca2+ concentrations. We show, from measurements of the kcat for actin-activated ATPase activity at saturating Ca2+ concentrations, that R146G TnI reduced the population of the active, M, state to 25% of the wild-type level. Together with acrylodan–tropomyosin fluorescence measurements of the B state, it appeared that the C state was populated at ∼91% of the total for the R146G TnI-containing actin filaments. The C state was also more heavily populated at low Ca2+ concentrations. Acrylodan–tropomyosin fluorescence changes showed a large diminution in the inactive state value relative to the wild-type value without a comparable increase in the active state. Furthermore, the rate of binding of rigor S1 to pyrene-labeled actin filaments containing R146G TnI was faster than the rate of binding to wild-type filaments at low free Ca2+ concentrations. These results indicate that the inhibitory region of TnI affects the B–C and M–C equilibria of actin–tropomyosin–troponin. The observation that a mutation in the inhibitory region affects the M–C equilibrium may point to a novel regulatory interaction.
- 3 August 2016
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 55 (32) , 4533-4540
The Cardiomyopathy Mutation, R146G Troponin I, Stabilizes the Intermediate “C” State of Regulated Actin under High- and Low-Free Ca2+ Conditions
The R146G mutation of troponin I (TnI) is associated with hypertrophic cardiomyopathy in humans. Earlier data pointed to stabilization of the intermediate, C state, of actin–tropomyosin–troponin by this mutant. Because cardiac disorders appear to be linked to changes in regulated actin distributions, we determined the extent to which the R146G TnI mutant alters the distribution of states at low and high Ca2+ concentrations. We show, from measurements of the kcat for actin-activated ATPase activity at saturating Ca2+ concentrations, that R146G TnI reduced the population of the active, M, state to 25% of the wild-type level. Together with acrylodan–tropomyosin fluorescence measurements of the B state, it appeared that the C state was populated at ∼91% of the total for the R146G TnI-containing actin filaments. The C state was also more heavily populated at low Ca2+ concentrations. Acrylodan–tropomyosin fluorescence changes showed a large diminution in the inactive state value relative to the wild-type value without a comparable increase in the active state. Furthermore, the rate of binding of rigor S1 to pyrene-labeled actin filaments containing R146G TnI was faster than the rate of binding to wild-type filaments at low free Ca2+ concentrations. These results indicate that the inhibitory region of TnI affects the B–C and M–C equilibria of actin–tropomyosin–troponin. The observation that a mutation in the inhibitory region affects the M–C equilibrium may point to a novel regulatory interaction.